IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of organic chemicals and bulk drugs.

Add Quick Ratio

Pros:

Company is expected to give good quarter

Cons:

Stock is trading at 4.38 times its book value

Though the company is reporting repeated profits, it is not paying out dividend

Company has a low return on equity of -1.21% for last 3 years.

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Detailed Comparison with:

	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018
	143	142	162	172	183	193	215	218	263	288	362	423
	126	117	137	147	158	167	189	189	230	255	322	348
Operating Profit	17	25	25	25	25	26	26	29	32	32	40	75
OPM %	12%	18%	16%	15%	14%	14%	12%	13%	12%	11%	11%	18%
Other Income	0	0	0	0	0	0	1	1	0	3	4	6
Interest	15	16	17	17	17	17	17	17	16	15	16	14
Depreciation	7	7	7	7	8	7	7	8	8	8	8	8
Profit before tax	-6	2	1	1	1	2	3	6	10	13	20	59
Tax %	-8%	29%	30%	25%	23%	14%	6%	24%	8%	10%	27%	35%
Net Profit	-6	1	1	1	1	2	3	4	9	11	14	38
	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	TTM
	202	316	301	347	387	471	482	564	385	580	711	983	1,335
	183	280	268	309	319	402	392	468	373	529	608	859	1,155
Operating Profit	19	36	33	39	68	69	89	96	11	51	102	125	180
OPM %	9%	12%	11%	11%	18%	15%	18%	17%	3%	9%	14%	13%	13%
Other Income	0	0	3	1	2	2	3	1	1	1	1	1	13
Interest	7	13	15	15	37	43	57	60	59	61	68	64	60
Depreciation	3	7	10	10	24	24	31	32	29	30	30	30	31
Profit before tax	9	16	11	15	9	4	3	5	-75	-39	6	31	101
Tax %	13%	24%	-14%	32%	32%	-25%	46%	35%	12%	-4%	21%	12%
Net Profit	8	12	13	10	6	5	2	3	-67	-40	5	28	73
EPS in Rs	7.99	9.24	6.99	4.41	2.40	1.85	0.61	1.15	0.00	0.00	0.83	4.93
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	-0%	-0%	0%	0%

* Sales is net of excise duty and discounts

	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Sep 2018
	14	18	23	28	31	31	31	49	48	56	56	56	56
Reserves	19	48	79	116	140	142	142	160	154	129	132	160	212
Borrowings	102	113	247	269	337	394	400	357	400	453	447	422	350
	58	82	93	134	141	175	211	247	160	197	252	257	216
Total Liabilities	188	256	437	542	644	738	779	793	762	835	888	895	834
	78	127	123	373	351	462	430	411	403	400	374	406	420
CWIP	36	26	187	1	57	12	32	33	4	4	21	7	12
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
	75	103	127	169	236	264	318	349	355	431	492	482	402
Total Assets	188	256	437	542	644	738	779	793	762	835	888	895	834

	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018
	15	22	16	31	24	55	53	78	-47	18	83	120
	-64	-47	-167	-67	-69	-87	-18	-12	-5	-27	-23	-50
	50	25	154	35	59	23	-32	-66	50	9	-60	-70
Net Cash Flow	1	0	3	-0	13	-9	3	1	-2	-0	1	-1

	Mar 2007	Mar 2008	Mar 2009	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018
ROCE %	15%	19%	10%	8%	10%	9%	11%	11%	-3%	4%	12%	15%
Debtor Days	34	37	31	32	29	17	27	32	31	55	58	52
Inventory Turnover	7.82	9.72	6.90	5.83	4.65	4.07	3.26	3.17	1.90	2.63	2.90	4.18